Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Point-Of-Care Molecular Diagnostics Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?#_x000D_
The point-of-care molecular diagnostics market size has experienced swift expansion over the last few years. It is projected to increase from $3.98 billion in 2025 to $4.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. The growth observed in previous periods stems from factors such as the rising occurrence of infectious diseases, the broadening scope of emergency diagnostic testing, an elevated need for swift clinical decision support, advancements in molecular assay technologies, and the expanding implementation of POC diagnostics in hospital environments._x000D_
_x000D_
The point-of-care molecular diagnostics market is anticipated to expand rapidly in the near future. By 2030, this market is set to reach a valuation of $7.91 billion, demonstrating a compound annual growth rate (CAGR) of 14.7%. Key drivers for this growth during the projected timeframe include the rising popularity of home-based molecular testing, greater investments in infrastructure for rapid diagnostics, broader applications for respiratory and oncology testing, increased incorporation of cloud-based diagnostic platforms, and a heightened emphasis on detecting diseases at early stages. Significant trends anticipated in the forecast period encompass a wider uptake of rapid molecular testing platforms, a growing need for decentralized diagnostic options, more widespread integration of automated sample processing, an enlargement of syndromic testing panels, and an intensified focus on achieving quick turnaround times._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Point-Of-Care Molecular Diagnostics Market Growth Backed By Core Demand Fundamentals#_x000D_
The quick rise in the incidence of infectious and respiratory ailments is anticipated to substantially fuel the expansion of the point-of-care molecular diagnostics market. Respiratory infections, which include viruses or bacteria, originate from microorganisms affecting the respiratory system. These tiny organisms can spread via coughing, sneezing, or physical contact. Treating severe respiratory conditions involves various methods like inhalers, oral medicines, intravenous therapies, and point-of-care molecular diagnostic tools for patient recovery. For example, data from June 2024, released by the UK Health Security Agency, a UK-based government body, indicated that from week 40 of 2022 to week 15 of 2023, 108 NHS trusts in England recorded 1,681 critical care admissions due to confirmed influenza. This contrasts with the prior season, where 182 admissions were noted across 114 trusts, rising to 316 by week 39 of 2022. Consequently, the swift emergence of infectious and respiratory diseases, along with associated fatalities, will propel the point-of-care molecular diagnostics market forward._x000D_
_x000D_
#Point-Of-Care Molecular Diagnostics Market Segment Performance And Emerging Opportunities#_x000D_
The point-of-care molecular diagnostics market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Assays And Kits, Instruments And Analyzers_x000D_
2) By Application: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections_x000D_
3) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities_x000D_
_x000D_
Subsegments:_x000D_
1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables_x000D_
2) By Instruments And Analyzers: Microfluidic Devices, Point-of-Care Analyzers_x000D_
_x000D_
#Point-Of-Care Molecular Diagnostics Market Growth Trends Reshaping The Competitive Landscape#_x000D_
Leading companies operating within the point-of-care molecular diagnostics market are concentrating on delivering technologically advanced solutions to strengthen their market standing. These businesses are adopting next-generation point-of-care molecular diagnostics technologies solutions and associated services, such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, among others, for implementation on POC devices designed to accelerate analysis times and lower costs. For instance, in May 2023, Sensible Diagnostics, a US-based diagnostics company, introduced a 10-minute point-of-care PCR system. Sensible Diagnostics is drawing upon the experience Curative gained with its diagnostics business throughout the pandemic. The firm stated it has conducted over two million molecular point-of-care COVID-19 tests, and its PCR platform offers a 10-minute time-to-result._x000D_
_x000D_
#Point-Of-Care Molecular Diagnostics Market Company Landscape And Competitive Strategy#_x000D_
Major companies operating in the point-of-care molecular diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, BioMérieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc _x000D_
_x000D_
#View The Full Point-Of-Care Molecular Diagnostics Market Report:#_x000D_
_x000D_
#Point-Of-Care Molecular Diagnostics Market Largest Region: Which Geography Holds The Biggest Share?#_x000D_
North America was the largest region in the point-of-care molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.